Osteoporos
Senast uppdaterad: Senast reviderad:
Sakkunnig:Anna Nager
Definition:
En systemisk skelettsjukdom med minskad benmassa och förändringar i benvävnadens mikroarkitektur som medför skört skelett och ökad risk för frakturer.
Förekomst:
I Sverige har knappt 6 % osteoporos, varav nästan 80 % är kvinnor. Förekomsten ökar kraftigt med åldern.
Symtom:
Osteoporos ger sällan några symtom innan en fraktur inträffar och den låga bentätheten är viktig att identifiera på grund av att den är en riskfaktor för kommande frakturer.
Kliniska fynd:
Fraktur efter litet eller inget trauma är det viktigaste tecknet på osteoporos men kliniska fynd kan också vara lågt BMI, längdminskning >3 cm jämfört med maxlängd som ung eller uttalad torakal kyfos som tecken på tidigare kotfrakturer.
Diagnostik:
Beslut om benspecifik läkemedelsbehandling grundas på en samlad klinisk bedömning. Särskilt stark behandlingsindikation föreligger vid fraktur i kota eller höft.
Behandling:
Benspecifika läkemedel, eventuellt med tilläggsbehandling med kalcium och D-vitamin, men också livsstilsförändringar såsom ökad fysisk aktivitet, träning av styrka och balans samt rökstopp.
- Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993 Jun;94(6):646–50. PMID: 8506892. PubMed
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1–129. PMID: 7941614. PubMed
- Bandeira L, Silva BC, Bilezikian JP. Male osteoporosis. Arch Endocrinol Metab. 2022 Nov 11;66(5):739-747. doi: 10.20945/2359-3997000000563. PMID: 36382763 PubMed
- Writing Group for the ISCD Position Development Conference. Position statement : executive summary. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference. J Clin Densitom. 2004 Spring;7(1):7-12. doi: 10.1385/jcd:7:1:7. PMID: 14742882 PubMed
- Warriner AH, Patkar NM, Curtis JR et al. Which fractures are most attributable to osteoporosis? J Clin Epidemiol. 2011 Jan;64(1):46-53. PMID: 21130353 PubMed
- Willers C, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Borgström F, Kanis JA; SCOPE review panel of the IOF. Osteoporosis in Europe: a compendium of country-specific reports. Arch Osteoporos. 2022 Jan 26;17(1):23. doi: 10.1007/s11657-021-00969-8. PMID: 35079919 PubMed
- Starup-Linde J, Rosendahl SB, Storgaard M, Langdahl B. Management of osteoporosis in patients living with HIV - a systematic review and meta-analysis. J Acquir. Immune Defic Syndr 2020; 83: 1-8. pmid:31809356 PubMed
- Crandall CJ, Larson JCLaCroix AZ, et al. Risk of Subsequent Fractures in Postmenopausal Women After Nontraumatic vs Traumatic Fractures. JAMA Intern Med 2021. pmid:34096979 PubMed
- Nationella riktlinjer för rörelseorganens sjukdomar (hämtad 2021-10-06) www.socialstyrelsen.se
- Vårdprogram för osteoporos, 2020/2021. Svenska osteoporossällskapet. Hämtad 2023-09-12 svos.se
- NKK. Nationellt kliniskt kunskapsstöd. Osteoporos. Hämtad 2023-09-15 www.nationelltklinisktkunskapsstod.se
- Läkemedel vid osteoporos för att förhindra benskörhetsfrakturer - behandlingsrekommendation. Läkemedelsverket, 2020 www.lakemedelsverket.se
- Shevroja E, Lamy O, Kohlmeier L, Koromani F, Rivadeneira F, Hans D. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice. J Clin Densitom 2017;20:334–45. PMID: 28734710 PubMed
- De Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BC. Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials. Osteoporos Int. 2009 Dec;20(12):2111-25. PMID: 19421702 PubMed
- Gillespie LD, Robertson MC, Gillespie W et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007146. doi: 10.1002/14651858.CD007146.pub3. PMID: 22972103 PubMed
- Sherrington C, Whitney JC, Lord SR, et al. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc. 2008 Dec;56(12):2234-43. PMID: 19093923. PubMed
- Pirruccio K, Yoon YM, Ahn J et al. Fractures in Elderly Americans Associated With Walking Leashed Dogs. JAMA Surg. 2019 Mar 6. PMID: 30840050 PubMed
- Santesso N, Carrasco-Labra A, Brignardello-Petersen R. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2014; 3: CD001255. doi:10.1002/14651858.CD001255.pub5. PMID: 24687239 PubMed
- Koike T, Orito Y, Toyoda H, et al. External hip protectors are effective for the elderly with higher-than-average risk factors for hip fractures. Osteoporosis Int 2009; 20: 1613.20. PMID:19137351. PubMed
- Thorin MH, Wihlborg A, Åkesson K, Gerdhem P. Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years. Osteoporos Int 2016;27:249–55. PMID: 26302684 PubMed
- Zhang X, Yu Z, Yu M, Qu X. Alcohol consumption and hip fracture risk. Osteoporos Int 2015;26:531–42. PMID: 25266483 PubMed
- Deardorff WJ, Cenzer I, Nguyen B, Lee SJ. Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. 2021 Nov 22:e216745. doi: 10.1001/jamainternmed.2021.6745. Epub ahead of print. PMID: 34807231 PubMed
- Wells GA, Cranney A, Peterson J, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001155. doi: 10.1002/14651858.CD001155.pub2. PMID: 18253985 PubMed
- Black DM, Delmas PD, Eastell R et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809–22. PMID: 17476007 PubMed
- Freemantle N, Cooper C, Diez-Perez A et al. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int 2013;24:209–17. PMID: 22832638 PubMed
- Popp AW, Senn R, Curkovic et al. Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 2017;28:1995–2002. PMID: 28299378 PubMed
- Bone HG, Wagman RB, Brandi ML et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 2017;5:513–23. PMID: 28546097 PubMed
- Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen J-EB, McClung M, et al. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension. J Bone Miner Res 2018;33:190–8. PMID: 29105841 PubMed
- Lorentzon M. Treating osteoporosis to prevent fractures: current concepts and future developments. J Intern Med. 2019 Apr;285(4):381-394. doi: 10.1111/joim.12873. Epub 2019 Jan 18. PMID: 30657216 PubMed
- Nationella riktlinjer för rörelseorganens sjukdomar, 2021. Socialstyrelsen. www.socialstyrelsen.se
- Händel MN, Cardoso I, von Bülov C, et al. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ 2023; 381: e068033. pmid:37130601 PubMed
- Kendler DL, Marin F, Zerbini CAF et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018 Jan 20;391(10117):230-240. doi: 10.1016/S0140-6736(17)32137-2. Epub 2017 Nov 9. Erratum in: Lancet. 2017 Nov 30;: Erratum in: Lancet. 2018 Dec 1;392(10162):2352. PMID: 29129436 PubMed
- Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. N Engl J Med. 2017 Oct 12;377(15):1417-1427. PMID: 28892457. PubMed
- Cosman F, Crittenden DB, Adachi JD et al. Romosozumab Treatment in Postmenopausal Women with Osteoporosis. N Engl J Med. 2016 Oct 20;375(16):1532-1543. doi: 10.1056/NEJMoa1607948. Epub 2016 Sep 18. PMID: 27641143 PubMed
- Nordiska Näringsrekommendationer 2012. Livsmedelsverket. www.livsmedelsverket.se
- Landfeldt E, Ström O, Robbins S, Borgström F. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 2012;23:433–43. PMID: 21286686 PubMed
- Bell KJ, Hayen A, Glasziou P et al. Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data. J Bone Miner Res Off J Am Soc Bone Miner Res 2016;31:1767–73. PMID: 27027655 PubMed
- Austin M, Yang YC, Vittinghoff E, et al. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res. 2012 Mar;27(3):687-93. PMID: 22095631. PubMed
- Black DM, Abrahamsen B, Bouxsein ML et al. Atypical Femur Fractures – Review of epidemiology, relationship to bisphosphonates, prevention and clinical management. Endocr Rev. 2018 Aug 29. PMID: 30169557 PubMed
- Jung SY, Suh HS, Park JW, Kwon JW. Drug Holiday Patterns and Bisphosphonate-Related Osteonecrosis of the Jaw. Oral Dis. Oral Dis. 2018 Aug 28. PMID: 30153366 PubMed
- Black DM, Schwartz AV, Ensrud KE et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 2006;296:2927–38. PMID: 17190893 PubMed
- Maraka S, Kennel KA. Bisphosphonates for the prevention and treatment of osteoporosis. BMJ 2015;351:h3783. PMID: 26333528 PubMed
- Adler RA, El-Hajj Fuleihan G et al. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res Off J Am Soc Bone Miner Res 2016;31:16–35. PMID: 26350171 PubMed
- Schwartz AV, Bauer DC, Cummings SR et al. Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res Off J Am Soc Bone Miner Res 2010;25:976–82. PMID: 20200926 PubMed
- Anagnostis P, Paschou SA, Mintziori G al. Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement. Maturitas 2017;101:23–30. PMID: 28539165 PubMed
- Abrahamsen B, Eiken P, Prieto-Alhambra D, Eastell R. Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. BMJ 2016;353:i3365. PMID: 27353596 PubMed
- Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K. Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med 2014;371:974–6. PMID: 25184886 PubMed
- Khan M, Cheung AM, Khan AA. Drug-Related Adverse Events of Osteoporosis Therapy. Endocrinol Metab Clin North Am 2017;46:181–92. PMID: 28131131 PubMed
- Hayashida S, Soutome S, Yanamoto S et al. Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis. J Bone Miner Res 2017;32:2022–9. PMID: 28585700 PubMed
- Gourlay ML, Fine JP, Preisser JS, et al. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med 2012; 366: 225-33. PMID: 22256806 PubMed
- Johnston CB, Dagar M. Osteoporosis in Older Adults. Med Clin North Am. 2020 Sep;104(5):873-884. doi: 10.1016/j.mcna.2020.06.004. Epub 2020 Jul 15. PMID: 32773051 PubMed
- Cummings SR, Lui L-Y, Eastell R, Allen IE. Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates A Meta-analysis. JAMA Intern Med 2019. pmid:31424486 PubMed
- Experten svarar: Bentäthetsmätningar. Tidningen Evidens. Janusinfo. Region Stockholm. Hämtad 2020-12-16 janusinfo.se
- Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet